Common genetic variation in the ATP-binding cassette transporter A1, plasma lipids, and risk of coronary heart disease

Atherosclerosis

Volumn 195, Issue 1, 2007, Pages

  Jensen, Majken K ^a,b,c   Pai, Jennifer K ^a   Mukamal, Kenneth J ^d   Overvad, Kim ^b,c   Rimm, Eric B ^a,e  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

ATP binding cassette transporter A1; Coronary heart disease; Genetic epidemiology; Plasma lipids; Reverse cholesterol transport

Indexed keywords

ABC TRANSPORTER A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; FOLLOW UP; GENETIC VARIABILITY; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MORPHOLOGICAL TRAIT; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALLELES; ATP-BINDING CASSETTE TRANSPORTERS; CORONARY DISEASE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LINKAGE DISEQUILIBRIUM; LIPIDS; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; VARIATION (GENETICS);

EID: 35248832546     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.01.025     Document Type: Article

References (37)

1. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., and Dawber T.R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 62 (1977) 707-714
2. Assmann G., and Nofer J.R. Atheroprotective effects of high-density lipoproteins. Annu Rev Med 54 (2003) 321-341
3. Oram J.F. HDL apolipoproteins and ABCA1: partners in the removal of excess cellular cholesterol. Arterioscler Thromb Vasc Biol 23 (2003) 720-727
4. Singaraja R.R., Brunham L.R., Visscher H., Kastelein J.J., and Hayden M.R. Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler Thromb Vasc Biol 23 (2003) 1322-1332
5. Brunham L.R., Singaraja R.R., and Hayden M.R. Variations on a gene: rare and common variants in ABCA1 and their impact on HDL cholesterol levels and atherosclerosis. Annu Rev Nutr 26 (2006) 105-129
6. Frikke-Schmidt R., Nordestgaard B.G., Jensen G.B., and Tybjaerg-Hansen A. Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J Clin Invest 114 (2004) 1343-1353
7. Tregouet D.A., Ricard S., Nicaud V., et al. In-depth haplotype analysis of ABCA1 gene polymorphisms in relation to plasma ApoA1 levels and myocardial infarction. Arterioscler Thromb Vasc Biol 24 (2004) 775-781
8. Clee S.M., Zwinderman A.H., Engert J.C., et al. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation 103 (2001) 1198-1205
9. Brousseau M.E., Bodzioch M., Schaefer E.J., et al. Common variants in the gene encoding ATP-binding cassette transporter 1 in men with low HDL cholesterol levels and coronary heart disease. Atherosclerosis 154 (2001) 607-611
10. Kakko S., Kelloniemi J., von Rohr P., et al. ATP-binding cassette transporter A1 locus is not a major determinant of HDL-C levels in a population at high risk for coronary heart disease. Atherosclerosis 166 (2003) 285-290
11. Andrikovics H., Pongracz E., Kalina E., et al. Decreased frequencies of ABCA1 polymorphisms R219K and V771M in Hungarian patients with cerebrovascular and cardiovascular diseases. Cerebrovasc Dis 21 (2006) 254-259
12. Zwarts K.Y., Clee S.M., Zwinderman A.H., et al. ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels. Clin Genet 61 (2002) 115-125
13. Kyriakou T., Hodgkinson C., Pontefract D.E., et al. Genotypic effect of the -565C>T polymorphism in the ABCA1 gene promoter on ABCA1 expression and severity of atherosclerosis. Arterioscler Thromb Vasc Biol 25 (2005) 418-423
14. Lutucuta S., Ballantyne C.M., Elghannam H., Gotto Jr. A.M., and Marian A.J. Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy. Circ Res 88 (2001) 969-973
15. Martin M., Gonzalez P., Reguero J.J., et al. ABCA1 polymorphisms and prognosis after myocardial infarction in young patients. Int J Cardiol 110 (2006) 267-268
16. Hodoglugil U., Williamson D.W., Huang Y., and Mahley R.W. Common polymorphisms of ATP binding cassette transporter A1, including a functional promoter polymorphism, associated with plasma high density lipoprotein cholesterol levels in Turks. Atherosclerosis 183 (2005) 199-212
17. Probst M.C., Thumann H., Aslanidis C., et al. Screening for functional sequence variations and mutations in ABCA1. Atherosclerosis 175 (2004) 269-279
18. Colditz G.A., Manson J.E., and Hankinson S.E. The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health 6 (1997) 49-62
19. Willett W.C. Nutritional epidemiology. 2nd ed. (1998), Oxford University Press, New York
20. Prentice R.L., and Breslow N.E. Retrospective studies and failure time models. Biometrika 65 (1978) 153-158
21. Kroenke C.H., Chu N.F., Rifai N., et al. A cross-sectional study of alcohol consumption patterns and biologic markers of glycemic control among 459 women. Diab Care 26 (2003) 1971-1978
22. Shai I., Stampfer M.J., Ma J., et al. Homocysteine as a risk factor for coronary heart diseases and its association with inflammatory biomarkers, lipids and dietary factors. Atherosclerosis 177 (2004) 375-381
23. White H.A. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica 48 (1980) 817-838
24. Kraft P., Cox D.G., Paynter R.A., Hunter D., and De V. I. Accounting for haplotype uncertainty in matched association studies: a comparison of simple and flexible techniques. Genet Epidemiol 28 (2005) 261-272
25. Zaykin D.V., Westfall P.H., Young S.S., et al. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 53 (2002) 79-91
26. Wang J., Burnett J.R., Near S., et al. Common and rare ABCA1 variants affecting plasma HDL cholesterol. Arterioscler Thromb Vasc Biol 20 (2000) 1983-1989
27. Benton J.L., Ding J., Tsai M.Y., et al. Associations between two common polymorphisms in the ABCA1 gene and subclinical atheroscleroris: multi-Ethnic Study of Atherosclerosis (MESA). Atheroscleroris 193 (2007) 352-360
28. Haghpassand M., Bourassa P.A., Francone O.L., and Aiello R.J. Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. J Clin Invest 108 (2001) 1315-1320
29. Aiello R.J., Brees D., Bourassa P.A., et al. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler Thromb Vasc Biol 22 (2002) 630-637
30. Francone O.L., Royer L., Boucher G., et al. Increased cholesterol deposition, expression of scavenger receptors, and response to chemotactic factors in Abca1-deficient macrophages. Arterioscler Thromb Vasc Biol 25 (2005) 1198-1205
31. Talmud P.J., Hawe E., Robertson K., et al. Genetic and environmental determinants of plasma high density lipoprotein cholesterol and apolipoprotein AI concentrations in healthy middle-aged men. Ann Hum Genet 66 (2002) 111-124
32. Kelley G.A., and Kelley K.S. Aerobic exercise and HDL2-C: a meta-analysis of randomized controlled trials. Atherosclerosis 184 (2006) 207-215
33. Garrison R.J., Kannel W.B., Feinleib M., et al. Cigarette smoking and HDL cholesterol: the Framingham offspring study. Atherosclerosis 30 (1978) 17-25
34. Wells G., and Herrington D.M. The Heart and Estrogen/Progestin Replacement Study: what have we learned and what questions remain?. Drugs Aging 15 (1999) 419-422
35. Mensink R.P., and Katan M.B. Effect of dietary fatty acids on serum lipids and lipoproteins: a meta-analysis of 27 trials. Arteriosclerosis Thrombosis 12 (1992) 911-919
36. Wang Y., and Oram J.F. Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a phospholipase D2 pathway. J Biol Chem 280 (2005) 35896-35903
37. Wang Y., Kurdi-Haidar B., and Oram J.F. LXR-mediated activation of macrophage stearoyl-CoA desaturase generates unsaturated fatty acids that destabilize ABCA1. J Lipid Res 45 (2004) 972-980